Suppr超能文献

[同型半胱氨酸与甲基丙二酸。新的检测项目——有何益处?]

[Homocysteine and methylmalonic acid. New tests--for what benefit?].

作者信息

Berentsen S, Talstad I

机构信息

Hematologisk seksjon, Haukeland Sykehus, Bergen.

出版信息

Tidsskr Nor Laegeforen. 1996 Sep 20;116(22):2677-9.

PMID:8928147
Abstract

A serum cobalamin level lower than 250 pmol/l combined with high values of plasma homocysteine and serum methylmalonic acid confirms the diagnosis of vitamin B12 deficiency. A low serum and erythrocyte folate level and high plasma homocysteine confirm folate deficiency. If the cobalamin level is higher than 250 pmol/l no further tests are needed. In patients with neurologic or psychiatric disorders combined with elevated levels of homocysteine and methylmalonic acid, cobalamin deficiency is likely if these levels decrease during vitamin B12 therapy. The causes of elevated homocysteine levels are often obscure, and homocysteine should therefore not be used as a screening test.

摘要

血清钴胺素水平低于250 pmol/l,同时伴有血浆同型半胱氨酸和血清甲基丙二酸水平升高,可确诊维生素B12缺乏。血清和红细胞叶酸水平低以及血浆同型半胱氨酸水平高可确诊叶酸缺乏。如果钴胺素水平高于250 pmol/l,则无需进一步检查。对于患有神经或精神疾病且同型半胱氨酸和甲基丙二酸水平升高的患者,如果在维生素B12治疗期间这些水平下降,则可能存在钴胺素缺乏。同型半胱氨酸水平升高的原因通常不明,因此同型半胱氨酸不应作为筛查试验。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验